Results 131 to 140 of about 73,039 (208)

Differential response to Janus kinase inhibitors in refractory livedoid vasculopathy: Biomarker-guided therapy may improve clinical response. [PDF]

JAAD Int
Yu G, Zhu J, Zhang Y, Yang F, Yang J, Tao J.   +5 more
europepmc   +1 more source

Cardiovascular and Thromboembolic Risk of Janus Kinase Inhibitors Compared to Other Disease-Modifying Drugs in Patients with Rheumatoid Arthritis: A Systematic Review and Meta-Analysis. [PDF]

J Pers Med
Ioannidis DC, Kapasouri EM, Vassiliou VS, Ntatsaki E.   +3 more
europepmc   +1 more source

Response to letter regarding 'Cardiovascular safety of Janus kinase inhibitors in inflammatory bowel disease: a systematic review and network meta-analysis'. [PDF]

Ann Med
Yang H, An T, Zhang Q.
europepmc   +1 more source

Impaired cellular immune responses to herpes zoster subunit vaccine in patients with rheumatoid arthritis receiving Janus kinase inhibitors. [PDF]

Rheumatology (Oxford)
Källmark H, Gullstrand B, Kahn F, Grenmyr E, Kahn R, Einarsson JT, Bengtsson AA, Kapetanovic MC.   +7 more
europepmc   +1 more source

Letter to the editor regarding to 'cardiovascular safety of janus kinase inhibitors in inflammatory bowel disease: a systematic review and network meta-analysis'. [PDF]

Ann Med
Liu S, Zhang L.
europepmc   +1 more source

Effects of Janus Kinase Inhibitors on Rheumatoid Arthritis Pain: Clinical Evidence and Mechanistic Pathways. [PDF]

Biomedicines
Belančić A, Sener S, Sener YZ, Fajkić A, Vučković M, Markotić A, Benić MS, Potočnjak I, Pavlović MR, Radić J, Radić M.   +10 more
europepmc   +1 more source

Machine learning-based prediction of response to Janus kinase inhibitors in patients with rheumatoid arthritis using clinical data. [PDF]

Front Immunol
Lee YJ, Choi G, Yeo J, Baek J, Choi H, Kim M, Kim YG, Kim BY, Koo J.   +8 more
europepmc   +1 more source

Herpes Zoster Risk in Rheumatoid Arthritis Patients on Janus Kinase Inhibitors: A 17-Year Experience from Rheumatoid Arthritis Saudi Database (RASD). [PDF]

Open Access Rheumatol
Abudaowd O, Attar SM, Siddiqui MI, Ahmed FM, Asiri A, Alomair MM, Ali AR, Alsharaif M, AlMalki H, Bahlas S, Bawazir Y, Salama G, Hussain A, Kaki R, Almoallim HM.   +14 more
europepmc   +1 more source

Janus kinase inhibitors in palmoplantar pustulosis: a mixed-methods feasibility (JAKPPPOT) trial protocol. [PDF]

BMJ Open
Gleeson D, Chapman S, McAteer H, Qin A, Gregory J, Pizzato J, Powell K, Sagoo MK, Ye W, Naylor A, Moorhead L, Pink AE, Woolf R, Barker J, Galloway JB, Cro S, K Mahil S, Smith CH.   +17 more
europepmc   +1 more source

Discontinuation and restart of Janus kinase inhibitors due to pregnancy in alopecia areata: a case series. [PDF]

Int J Womens Dermatol
Ogbutor C, Chen LC, Kalil LL, Kelley KJ, Craiglow BG, King B, Senna MM.   +6 more
europepmc   +1 more source